Valentina Albanese

Via Luigi Borsari 46
Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d-Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1-15)-NH2.

Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d-Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1-15)-NH2.

Journal: Journal of medicinal chemistry

Published: July 23, 2026

Not Quite Folded: Challenges in Predicting the hNPS-hNPSR-Ile107 Complex With AlphaFold2 Multimer.

Not Quite Folded: Challenges in Predicting the hNPS-hNPSR-Ile107 Complex With AlphaFold2 Multimer.

Journal: ChemMedChem

Published: May 26, 2026

NOP receptor activation counteracts stress-induced migraine-like behaviors in mice.

NOP receptor activation counteracts stress-induced migraine-like behaviors in mice.

Journal: Neuropharmacology

Published: April 07, 2026

Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands.

Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands.

Journal: Journal of medicinal chemistry

Published: November 04, 2025

Design and synthesis of 1,4,8-triazaspiro[4.5]decan-2-one derivatives as novel mitochondrial permeability transition pore inhibitors.

Design and synthesis of 1,4,8-triazaspiro[4.5]decan-2-one derivatives as novel mitochondrial permeability transition pore inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: May 21, 2025

Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study.

Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 29, 2025

Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics.

Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics.

Journal: European journal of medicinal chemistry

Published: April 22, 2025

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice.

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice.

Journal: British journal of pharmacology

Published: April 10, 2025

FAP inhibitors: are we really using the best method to evaluate the residence time?

FAP inhibitors: are we really using the best method to evaluate the residence time?

Journal: European journal of nuclear medicine and molecular imaging

Published: February 25, 2025

Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo.

Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo.

Journal: European journal of medicinal chemistry

Published: February 20, 2025

Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study.

Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study.

Journal: RSC medicinal chemistry

Published: September 24, 2024

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients.

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients.

Journal: Frontiers in immunology

Published: September 08, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026